A suppressor of cytokine signaling box-2 (ASB2) and retinoic acid receptor alpha (RARA), which promote normal hematopoiesis and the ATRA-induced APL differentiation of leukemia cells, are downregulated by FTO in an m6A-dependent manner76. Here, RARA is linked to leukemia.